A new FDA voucher program will aim to accelerate review time for applications that are deemed to be advancing U.S. “national priorities.”
Vinay Prasad, a MAHA-aligned hematologist-oncologist with an avid cyber following, who was named director of the FDA Center for Biologics Evaluation and Research in early May (The Cancer Letter, May 9, 2025), has now been also appointed chief medical and science officer at FDA, according to an internal memo obtained by The Cancer Letter.
FDA has announced that the agency will begin immediately reviewing all new clinical trials that include shipping American citizens’ living cells to “China and other hostile countries for genetic engineering and subsequent infusion” back into American patients.
Peter Voorhees was promoted to associate director of clinical research and will oversee clinical research for Atrium Health Wake Forest Baptist Comprehensive Cancer Center, as well as all processes related to clinical protocol and data management and protocol review and monitoring system.
UPMC Hillman Cancer Center physician scientist and melanoma researcher Yana Najjar, is the 2025 recipient of the Sy Holzer Endowed Immunotherapy Research Award to advance innovative research in cancer immunotherapy.
Samra Turajlić was appointed the director of the Cancer Research UK Manchester Institute.
2025 Dr. Eddie Méndez Scholar Award Recipients, top row left to right: Caitlin Cornell, PhD, Elizabeth Kaweesa, PhD, Leandro Fernández-García, PhD, Almudena Chaves Pérez, PhD. Bottom row left to right: Luis Cedeño-Rosario, PhD, Nicole Halmai, PhD, Megan E. Meuser, PhD, Sarah Elisabeth Pierce, PhD. Fred Hutch Cancer Center has announced eight recipients of the 2025 Dr. Eddie Méndez Scholar Award.
Justin Taylor, a physician-scientist at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, has received a Stanley J. Glaser Foundation Research Award to continue the research.
UNC Lineberger awarded up to $28M from ARPA-H to develop clinical trial for metastatic breast cancer
UNC Lineberger Comprehensive Cancer Center has been awarded up to $28 million by the Advanced Research Projects Agency for Health to lead the development of a next-generation clinical trial for breast cancer that has spread to other parts of the body.
City of Hope has been awarded an up to $23.7 million contract from the Advanced Research Projects Agency for Health within the U.S. Department of Health and Human Services. The grant will help City of Hope create a biomap of tumor changes that cause immunotherapy resistance in advanced or metastatic non-small cell lung cancer.
